Slide 1: Fourth Quarter and Full Year 2025 Earnings
Fourth Quarter and Full Year 2025 Earnings EARNINGS PRESENTATION February 4, 2026
Slide 2: Forward Looking Statements and Non-GAAP Financial Measures
Forward Looking Statements and Non-GAAP Financial Measures FORWARD-LOOKING STATEMENTS Statements in this presentation that are not strictly historical, including statements regarding anticipated financial results, global and regional economic conditions, industry trends, geopolitical events, future
Slide 3: Key Messages
Key Messages 1 Solid execution at new Fortive continues with Q4 performance ahead of expectations FY 2025 Adj. EPS of $2.71 exceeded high end of guidance 2 range ($2.63 - $2.67) ~$1.3B of share repurchases in second half of 2025 3 demonstrates continued commitment to disciplined capital allocation a
Slide 4: Fortive Accelerated Strategy
Fortive Accelerated Strategy 1 2 3 Faster Profitable Disciplined Capital Build and Maintain Organic Growth Allocation Investor Trust • Innovation Acceleration • Invest in organic growth • Clear expectations and consistent • Commercial Acceleration • Smaller bolt-on M&A delivery • Recurring Customer
Slide 5: Fortive Results
Fortive Results Q4 2025 and FY 2025 Q4 COMMENTARY Q4 2025 FY 2025 • Core growth of +3% reflects growth at both segments and growth across all major Revenue $1,123M $4,159M regions Reported Growth +4.6% +1.9% Core Growth +3.3% +1.7% • Adjusted Gross Profit up modestly year- over-year; Adj. Gross Marg
Slide 6: Intelligent Operating Solutions
Intelligent Operating Solutions Q4 2025 and FY 2025 Q4 2025 FY 2025 Q4 COMMENTARY • Core revenue growth of +4% with solid Revenue performance in professional $770M $2,856M Reported Growth +5.3% +2.3% instrumentation, Facilities and Asset Core Growth +4.1% +2.1% Lifecycle software, and gas detection
Slide 7: Advanced Healthcare Solutions
Advanced Healthcare Solutions Q4 2025 and FY 2025 Q4 2025 FY 2025 Q4 COMMENTARY • Core revenue growth of +1.6% driven Revenue by continued strength in healthcare $353M $1,303M Reported Growth +3.2% +1.2% software; demand trends for Core Growth +1.6% +0.8% healthcare equipment & consumables improved
Slide 8: Balance Sheet & Capital Allocation
Balance Sheet & Capital Allocation Q4 2025 and FY 2025 COMMENTARY Balance Sheet As of December 31, 2025 • Deployed ~$265M towards share Cash and equivalents $0.4B repurchase in Q4, representing ~5M Gross debt $3.2B shares at an average price of $51.80 • In second half of 2025, deployed ~$1.3B Net de
Slide 9: FY 2026 Guidance
FY 2026 Guidance Adj. EPS | FY 2026 $2.90 to $3.00 9
Slide 10: Fortive Accelerated
Fortive Accelerated Innovating essential technologies to keep our world safe and productive 10
Slide 11: Appendix & Supplemental Reconciliation Data
Appendix & Supplemental Reconciliation Data 11
Slide 12: 1H / 2H 2025 Results
1H / 2H 2025 Results Fortive IOS AHS 1H 2025 2H 2025 1H 2025 2H 2025 1H 2025 2H 2025 Revenue $2,009.5M $2,149.6M $1,387.8M $1,468.5M $621.7M $681.1M Reported Growth +0.3% +3.5% +0.5% +4.0% (0.3)% +2.5% Core Growth +0.7% +2.6% +0.9% +3.2% +0.2% +1.3% Adj. Gross Profit $1,289.7M 25% 26% 28% $1,362.4M
Slide 13: Core Revenue Growth
CORE REVENUE GROWTH Three Months Ended Components of Revenue Growth December 31, 2025 December 31, 2024 Intelligent Advanced Intelligent Advanced Operating Healthcare Total Fortive Operating Healthcare Total Fortive Solutions Solutions Solutions Solutions Total revenue growth (GAAP) 5.3 % 3.2 % 4.6
Slide 14: Adjusted Gross Profit and Adjusted Gross Profit Margin
ADJUSTED GROSS PROFIT AND ADJUSTED GROSS PROFIT MARGIN Three Months Ended December 31, 2025 Three Months Ended December 31, 2024 $ in millions Intelligent Advanced Total Intelligent Advanced Total Operating Healthcare Fortive Operating Healthcare Fortive Solutions Solutions Solutions Solutions Reven
Slide 15: Adjusted Gross Profit and Margin - First Half and Second Half
ADJUSTED GROSS PROFIT AND ADJUSTED GROSS PROFIT MARGIN - FIRST HALF AND SECOND HALF OF YEAR 1H 2025 1H 2024 $ in millions Intelligent Advanced Total Intelligent Advanced Total Operating Healthcare Fortive Operating Healthcare Fortive Solutions Solutions Solutions Solutions Revenue (GAAP) $ 1,387.8 $
Slide 16: Adjusted EBITDA and Adjusted EBITDA Margin from Continuing Operations
ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN FROM CONTINUING OPERATIONS Three Months Ended Year Ended $ in millions December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Revenue (GAAP) $ 1,122.5 $ 1,072.8 $ 4,159.1 $ 4,080.9 Net Earnings from Continuing Operations (GAAP) $ 191.5 $ 19
Slide 17: Adjusted EBITDA and Margin - First Half and Second Half
ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN FROM CONTINUING OPERATIONS - FIRST HALF AND SECOND HALF OF YEAR 1H 2H $ in millions 2025 2024 2025 2024 Revenue (GAAP) $ 2,009.5 $ 2,004.4 $ 2,149.6 $ 2,076.5 Net Earnings from Continuing Operations (GAAP) $ 224.2 $ 177.8 $ 308.5 $ 304.7 Interest expense, n
Slide 18: Operating Profit to Adjusted EBITDA Bridge
FORTIVE CONTINUING OPERATIONS: OPERATING PROFIT & OPERATING PROFIT MARGIN TO ADJUSTED EBITDA AND ADJUSTED MARGIN BRIDGE Three Months Ended Year Ended $ in millions December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Revenue (GAAP) $ 1,122.5 $ 1,072.8 $ 4,159.1 $ 4,080.9 Operating
Slide 19: Segment Adjusted EBITDA and Segment Adjusted EBITDA Margin
SEGMENT ADJUSTED EBITDA AND SEGMENT ADJUSTED EBITDA MARGIN Three Months Ended December 31, 2025 Three Months Ended December 31, 2024 $ in millions Intelligent Advanced Corporate Total Intelligent Advanced Corporate Total Operating Healthcare Fortive Operating Healthcare Fortive Solutions Solutions S
Slide 20: Segment Adjusted EBITDA and Segment Adjusted EBITDA Margin
SEGMENT ADJUSTED EBITDA AND SEGMENT ADJUSTED EBITDA MARGIN Year Ended December 31, 2025 Year Ended December 31, 2024 $ in millions Intelligent Advanced Corporate Total Intelligent Advanced Corporate Total Operating Healthcare Fortive Operating Healthcare Fortive Solutions Solutions Solutions Solutio
Slide 21: Segment Adjusted EBITDA and Margin - First Half and Second Half
SEGMENT ADJUSTED EBITDA AND SEGMENT ADJUSTED EBITDA MARGIN - FIRST HALF AND SECOND HALF OF YEAR 1H 25 1H 24 $ in millions Intelligent Advanced Corporate Total Intelligent Advanced Corporate Total Operating Healthcare Fortive Operating Healthcare Fortive Solutions Solutions Solutions Solutions Revenu
Slide 22: Adjusted Net Earnings and Adjusted Diluted Net EPS
ADJUSTED NET EARNINGS AND ADJUSTED DILUTED NET EPS FROM CONTINUING OPERATIONS Three Months Ended Year Ended $ in millions, except per share amounts December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Per share Per share Per share Per share value value value value Net Earnings and
Slide 23: Adjusted Net Earnings and Adjusted Diluted EPS - First Half and Second Half
ADJUSTED NET EARNINGS AND ADJUSTED DILUTED NET EPS FROM CONTINUING OPERATIONS - FIRST HALF AND SECOND HALF OF YEAR 1H 2H $ in millions, except per share amounts 2025 2024 2025 2024 Per share Per share Per share Per share value value value value Net Earnings and Net Earnings Per Share from Continuing
Slide 24: Free Cash Flow from Continuing Operations
FREE CASH FLOW FROM CONTINUING OPERATIONS (in millions) Three Months Ended Year Ended December 31, 2025 September 26, 2025 June 27, 2025 March 28, 2025 December 31, 2025 Operating Cash Flows from Continuing Operations (GAAP) $ 344.2 $ 294.7 $ 205.0 $ 191.8 $ 1,035.7 Less: Purchases of property, plan
Slide 25: @ FORTIVE ©Fortive2026 ©
@ FORTIVE ©Fortive2026 © 25